These Funding Opportunity Announcements (FOA) are associated with the Cancer MoonshotSM Initiative that is intended to accelerate cancer research. Specifically, these FOAs target the following area designated as scientific priority by the Blue Ribbon Panel (BRP):
Recommendation B. Create a translational science network devoted exclusively to immunotherapy approaches to treat and prevent adult cancers.
The FY2019 requests for applications have been closed. The earliest start date for the IOTN FY19 awardee will be September 2019, and the detailed information of awardees will be available at IOTN awardees.